PatientsVille.com Logo

LETHARGY and Gabapentin

PatientsVille

LETHARGY Symptoms and Causes

We are sorry, but no medical information on this topic currently exists in our database. Our articles are updated often, please revisit soon.

Check out the latest treatments for LETHARGY

LETHARGY treatment research studies

Gabapentin clinical trials, surveys and public health registries


Find Drug Side Effect reports



Gabapentin Side Effects

Completed Suicide (332)
Dizziness (329)
Somnolence (306)
Pain (288)
Headache (282)
Confusional State (265)
Nausea (256)
Off Label Use (227)
Tremor (223)
Fatigue (221)
Depression (214)
Fall (195)
Convulsion (184)
Feeling Abnormal (183)
Toxicity To Various Agents (176)
Suicidal Ideation (171)
Malaise (171)
Respiratory Arrest (163)
Cardiac Arrest (145)
Condition Aggravated (144)
Dyspnoea (113)
Pain In Extremity (112)
Myoclonus (108)
Anxiety (108)
Asthenia (107)
Amnesia (104)
Diarrhoea (102)
Insomnia (97)
Vision Blurred (90)
Gait Disturbance (85)
Vomiting (84)
Death (84)
Oedema Peripheral (83)
Disorientation (82)
Back Pain (80)
Rash (80)
Weight Increased (79)
Agitation (78)
Paraesthesia (74)
Memory Impairment (73)
Dyskinesia (73)
Abdominal Pain (73)
Hallucination (72)
Muscular Weakness (71)
Sedation (71)
Myalgia (70)
Loss Of Consciousness (70)
Renal Failure Acute (69)
Hypoaesthesia (66)
Muscle Spasms (66)

➢ More


Common Meds

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)
Zoloft(6792)
Zyrtec(1669)

Recent Reviews

Be careful! Avoid Gabapentin at all costs! My mother's doctor ordered a 900 mg/day dose. In the 2 years she was under this dose, she fell 5 times! No doctor 'suspected' this drug! Then, he increased the dose to...1800 mg/day! I almost lost her! I am

Dose Gabapantin have any ting to do with the nearves in your body

For the last two weeks I have been taking a lowish dose of Gabapentin for night-time nerve pain (100gm three times a day and then 200mg at night.) It has worked brilliantly for the pain and I was ecstatic BUT I have now wet the bed two nights in a r

GABAPENTIN noticed that medication got worsen n Nurgloist n don't listin. My problem n even rash n stomach ach n was getting stress out n decided go different doctor n was. Going take that chance with my n stop going to Nurgloist n been two.n bo

Great so far for my anxiety... just side effects has ... sexually saticfied,nausea little bit.. dizzynezz! lolz.. but great medication/ i think..

Having racing thoughts and unmotivated *DONT_KNOW*

Hear voices

Hello, I've been taking a cocktail of meds for 9 years to help treat acute nerve pain from a severe Brachial Plexus nerve avulsion C 7, 8, T1 and Spinal cord injury. Medications: Gabapentin 3600 mg., Methadone 100 mg. , Baclofen 20 mg. every 8 hour

I am having trouble falling to sleep, and I feel like I' having anxiety attacks I stopped the 400 Mg and I am taking 2 100 MGS now. I am doing this on my own , until I see my Dr next week. .

I am just starting Gabapentin to help with phantom pain from a BKA (below-knee-amputation). I am taking 600 mg and am scheduled to increase to 900 mg, then review results with my doctors. One of the side effects I seem to have is

After a pulmunary embolism diagnosis in April 2010, I was put on Warfarin for 11 months ... I was taken off it 1 week ago... While on it I experienced extreme lethargy , difficulty concentrating, memory loss, dizziness, ongoing ch

Burning sensation, confusion, mental states changes, lethargy, chest pain, pain, communication difficulty.88 years old with astma, high blood pressure, diabetes, prostate enlargement,

Evil drug. Side effects in order are, coughing, extreme lethargy, horrible dreams like ones where demons are torturing me that leave me with night terror as I wake up that takes a few minutes to go away, blurred vision, reduced sex drive, horrible he

Extreme bitter taste during the day & morning, extreme lethargy

Had to increase dosage to 1000mg twice a day. Immediately began to find it difficult to summon any energy to do any normal day to day acttivities eg washing, cooking. Diarhoea, lethargy, increase in thirst ( nothing quen

Hi, abt 5 mths ago iwas prescribed concor 5mg once aday on top of fortzaar 100mg once aday which doctor prescribed me as long as i remember abt 5 years ago. doc says combination of this drugs safe but why i feel somekind of lethargy or dull

I am experiencing severe lower back pain and lethargy since taking this medication. I have difficulty in breathing. My doctor changed me from duregesic patches to these.

I am suffering from lethargy. Could this be a side effect of epilim

I began having pain particularly in my knees and feet about one week after taking Forteo.Painis also in my hands and muscles. It seems to travel.I also noticed that I have lethargy and some depression.&nbsp

I haver been taking Movicil for some months and suffer weight loss, cramps in arms and legs, frequent passing of urine causing me to have to get up more and more in the night and a feeling of lethargy while feeling unwell. I have a rash under both

LETHARGY Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Rank Status Study
1 Recruiting Pilot Study For Hypothermia Treatment In Hyperammonemic Encephalopathy In Neonates And Very Young Infants
Conditions: Urea Cycle Disorders;   Organic Acidemias
Interventions: Other: Therapeutic Hypothermia;   Other: Standard of care therapy
Outcome Measures: Number of Participants with unexpected Serious Adverse Events as a Measure of Safety and Tolerability;   Feasibility of hypothermia therapy as adjunct therapy to the complex standard of care therapy;   Time to normalization of ammonia level
2 Recruiting Longitudinal Study of Urea Cycle Disorders
Conditions: Brain Diseases, Metabolic, Inborn;   Amino Acid Metabolism, Inborn Errors;   Urea Cycle Disorders
Intervention:
Outcome Measures: Prevalence of specific morbid indicators of disease severity;   Relationship between various biomarkers and disease severity and progression;   Safety and efficacy of currently used and new UCD therapies
3 Not yet recruiting Brain Imaging of Intranasal Oxytocin Treatment in Autism
Condition: Autism Spectrum Disorders
Intervention: Drug: Oxytocin
Outcome Measures: Aim 1a. fMRI Activation Analysis/Connectivity;   Aim 1b. Proportion of Time Attending to Social Stimuli (Eye Tracking);   Plasma Oxytocin (OT) levels in aim 1b. and 2b.;   Salivary Oxytocin (OT) levels for aim 1b and 2b.;   SRS-Social Responsiveness Scale;   Pervasive Developmental Disorders Behavior Inventory-Screening Version (PDDBI-SV);   ABC-Lethargy/social withdrawal subscale
4 Recruiting Proton Radiotherapy for Stage I, IIA, and IIB Seminoma
Condition: Stage I, IIA and IIB Seminoma
Intervention: Radiation: Proton Radiation Therapy
Outcome Measure: Number of Serious Adverse Events
5 Recruiting Study of Aripiprazole in the Treatment of Pervasive Developmental Disorders
Condition: Pervasive Developmental Disorder
Intervention: Drug: aripiprazole
Outcome Measures: Clinical Global Impression - Improvement;   Aberrant Behavior Checklist Irritability Scale;   The Aberrant Behavior Checklist Lethargy, Stereotypy, Hyperactivity and Inappropriate Speech Subscales
6 Recruiting Study to Evaluate the Efficacy and Safety of Aripiprazole
Condition: Autism
Intervention: Drug: Aripiprazole
Outcome Measures: irritability subscale of the aberrant behavior checklist;   Change from baseline in ABC-subscale of Lethargy/social withdrawal, stereotypic behavior, hyperactivity, inappropriate speech;   Change of CGI-S, CGI-I from baseline;   Change of Behavioral problems from baseline;   Change of Adaptive Skills from baseline;   Change of Parental stress from baseline
7 Recruiting Pediatric Autism Study
Condition: Autism
Interventions: Drug: Lurasidone 20 mg daily;   Drug: Lurasidone;   Drug: Placebo
Outcome Measures: Change from Baseline to Week 6 in the ABC irritability subscale;   Change from Baseline in Clinical Global Impression severity (CGI-S) scale;   Change in Clinical Global Impression Improvement (CGI-I) scale;   Change from Baseline in other Aberrant Behavior Checklist (ABC) subscale scores (hyperactivity, stereotypy, inappropriate speech, and Lethargy/social withdrawal);   Change from Baseline in Children's Yale-Brown Obsessive Compulsive Scales (CY-BOCS) modified for pervasive developmental disorders (PDDs);   Change from Baseline in the Caregiver Strain Questionnaire (CGSQ);   Proportion of subjects who have CGI-I score of 1 (very much improved) or 2 (much improved) at Week 6;   Proportion of subjects who have at least 25% reduction from Baseline to Week 6 in the ABC irritability subscale score.;   Number of Participants with Adverse Event Reporting;   Laboratory Tests - actual values and change from Baseline values for each time point measured.;   Vital Signs - actual values and change from Baseline values for each time point measured.;   Body Weight-Body Mass Index;   Waist Circumference;   Physical Examination - assessment of general appearance and a review of systems;   Height (as measured by stadiometer);   Electrocardiogram;   Barnes Akathisia Rating Scale (BARS);   Abnormal Involuntary Movement Scale (AIMS);   Simpson-Angus Scale (SAS);   Tanner Staging;   Menstrual Cyclicity - Menstrual cyclicity will be monitored in female subjects who have begun menses. At Baseline, female subjects will be given a calendar to mark the beginning and end of each menses.
8 Unknown  Treatment of Iron Deficiency Anemia in Malaria Endemic Ghana
Condition: Anemia
Interventions: Dietary Supplement: Sprinkles®;   Dietary Supplement: vitamin/mineral fortificant without iron
Outcome Measures: incidence of clinical malaria (if fever recorded a blood sample will be taken to determine parasite species and count);   changes in anemia status (blood levels of: haemoglobin(Hb) , ferritin (SF));   severity of clinical malaria (blood parasite count);   cerebral malaria (defined by a parasite count >5000/μL blood and a concurrent score of <2 on the Blantyre coma scale, with or without convulsions);   hospitalization (documentation of hospitalization for any reason);   death;   pneumonia (defined by the presence of a cough or breathing difficulties, tachypnea, lower chest wall indrawing, and the appearance of consolidation or pleural effusion on a chest X-ray);   diarrhea (defined by >3 loose or watery stools in the previous 24 hours);   dehydration (defined by Lethargy, sunken eyes, and decreased skin turgor [>2 seconds for skin to return following a skin pinch])
9 Unknown  Effect of Adjuvant Treatment With Compound Cranberry Extract Tablets in Acute Bacterial Cystitis.
Conditions: Pyuria;   Urinary Tract Infections
Intervention: Drug: compound cranberry extract tablet
Outcome Measures: Time to symptoms relief;   Pyuria eradication rate
10 Recruiting Supreme-LMA for Neonatal Resuscitation: a Prospective, Randomized Single-center Study
Condition: Neonatal Resuscitation
Interventions: Device: Supreme LMA;   Device: Facial mask
Outcome Measures: Proportion of newborns needing endotracheal intubation;   Time to first breath;   Proportion of patients needing Chest compressions and medications;   Proportion of patients with hypoxic ischemic encephalopathy
11 Recruiting A Randomized Comparison of Rifaximin Versus Lactulose in Hospitalized Cirrhotic Patients With Renal Failure
Condition: Hepatic Encephalopathy
Interventions: Drug: Rifaximin;   Drug: Lactulose
Outcome Measures: Development of Progressive Hepatic Encephalopathy to Stage 3 or 4 in patients with progressive renal failure;   In-hospital mortality;   Hospital Length of Stay